Bring your work to life with Allevi 3D bioprinters, materials, and reagents
Designed to do more for less. With the smallest footprint and widest material capabilities of any 3D bioprinter on the market, you’re going to love using the Allevi 1
Our most versatile lab-adapted, 3D bioprinter. Designed and optimized for research in tissue engineering, drug delivery, disease modeling and everything in-between
Your best-in-class entry level 3D bioprinter. Packing all the key features: duo temperature-controlled printheads and photocuring, the Allevi 2 delivers unmatched precision and versatility.
3D bioprinting allows researchers to create custom 3D tissues for research, investigate new disease models, formulate the next generation of bioinks, and study the body outside the body with a level of freedom and ease-of-use that was simply not possible as recently as 10 years ago.
Since we launched our first bioprinter, the first commercial desktop bioprinter in the world, our incredible community of users all over the globe has worked on groundbreaking research for the development of sugar stents to one day help surgeons join veins with fewer complications, systems for improved drug delivery, disease models for drug screening, and the bioprinting of tissues with translational aspirations in regenerative medicine. Check out our publications page to learn more about the work our users are doing.
Allevi by 3D Systems recognizes the power of democratizing technologies for scientists. We are proud partners of research institutions worldwide, enabling the study of bioprinting to one day achieve the enormous goals we have for the field: producing tissues that can better recapitulate human physiology for more effective drug testing, 3D bioprinting drug delivery systems for efficient and guided application of drugs to pathological sites, and printing tissues for regenerative (and personalized) medicine.
Used in more than
Featured in
Across
3D bioprinting technology continues to evolve and shape the way modern medicine approach the therapeutic research process. We present a short digest on what bioprinting experts sees as important milestones and movements in the 3D bioprinting world.
What if we could decrease pharmaceutical development’s dependence on animal studies while increasing clinical trial success and developing more safe and effective drugs? A bill recently passed unanimously by the United States Senate is at the heart of this discussion and can pave the way for the adoption of technologies that enable overcoming this challenging goal.
With recent advances in 3D bioprinting technology we welcome the development of new biomaterials and bioinks. Yu and colleagues, a group of researchers based in Taiwan, presents a potential new photocrosslinkable bioink based on keratin and chitosan that supports stem cell and spheroid loading and culture, paving ways for cell-laden biofabricated hydrogels development.
Shop online for bioink, syringes, nozzles, centrifuge tubes and everything else you need for bioprinting with Allevi.
